Selective p38α MAP kinase/MAPK14 inhibition in enzymatically modified LDL-stimulated human monocytes: implications for atherosclerosis.
Cheng F, Twardowski L, Fehr S, Aner C, Schaeffeler E, Joos T, Knorpp T, Dorweiler B, Laufer S, Schwab M, Torzewski M.
Cheng F, et al.
FASEB J. 2017 Feb;31(2):674-686. doi: 10.1096/fj.201600669R. Epub 2016 Nov 8.
FASEB J. 2017.
PMID: 27871059
Inhibition of a key signaling molecule of the p38 MAPK pathway, p38alpha MAPK/MAPK14, by selective inhibitors like skepinone-L, conclusively facilitates elucidation of the impact of the complex network of p38 MAPK signaling on atherogenesis and might provide a promising therapeut …
Inhibition of a key signaling molecule of the p38 MAPK pathway, p38alpha MAPK/MAPK14, by selective inhibitors like skepinone-L, conclusively …